Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications
Impact of Race, Socioeconomic Status, and Clinicopathologic Features on Clinical Outcomes in Triple-Negative Breast Cancer in the ECOG-ACRIN EA1131 Trial.
Journal: JCO oncology advances
Published: May 18, 2026
Adjuvant platinum versus capecitabine for residual, invasive, triple-negative breast cancer: Patient-reported outcomes in ECOG-ACRIN EA1131.
Journal: Cancer
Published: August 07, 2023
Cisplatin with veliparib or placebo in metastatic triple-negative breast cancer and BRCA mutation-associated breast cancer (S1416): a randomised, double-blind, placebo-controlled, phase 2 trial.
Journal: The Lancet. Oncology
Published: September 16, 2022
A randomised phase II trial of a trivalent ganglioside vaccine targeting GM2, GD2 and GD3 combined with immunological adjuvant OPT-821 versus OPT-821 alone in metastatic sarcoma patients rendered disease-free by surgery.
Journal: European journal of cancer (Oxford, England : 1990)
Published: June 03, 2022
Reply to T. Shimoi et al and Y. Shimanuki et al.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: September 23, 2021
Randomized Phase III Postoperative Trial of Platinum-Based Chemotherapy Versus Capecitabine in Patients With Residual Triple-Negative Breast Cancer Following Neoadjuvant Chemotherapy: ECOG-ACRIN EA1131.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: June 07, 2021
A Phase II Study Evaluating the Safety and Efficacy of Sunitinib Malate in Combination With Weekly Paclitaxel Followed by Doxorubicin and Daily Oral Cyclophosphamide Plus G-CSF as Neoadjuvant Chemotherapy for Locally Advanced or Inflammatory Breast Cancer.
Journal: Clinical breast cancer
Published: February 01, 2021
Results of a Randomized, Double-Blinded, Placebo-Controlled, Phase 2.5 Study of Saracatinib (AZD0530), in Patients with Recurrent Osteosarcoma Localized to the Lung.
Journal: Sarcoma
Published: November 18, 2019
Combined Targeted Therapies for First-line Treatment of Metastatic Triple Negative Breast Cancer-A Phase II Trial of Weekly Nab-Paclitaxel and Bevacizumab Followed by Maintenance Targeted Therapy With Bevacizumab and Erlotinib.
Journal: Clinical breast cancer
Published: September 18, 2018
Clinical benefit of antiangiogenic therapy in advanced and metastatic chondrosarcoma.
Journal: Medical oncology (Northwood, London, England)
Published: July 09, 2017
Phase I Study of Veliparib (ABT-888) Combined with Cisplatin and Vinorelbine in Advanced Triple-Negative Breast Cancer and/or BRCA Mutation-Associated Breast Cancer.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: September 08, 2015
Analysis of clinical prognostic factors for adult patients with head and neck sarcomas.
Journal: Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery
Published: September 27, 2014
Last Updated: 09/26/2026